Clinics' Pitch to Indian Émigrés: It's a Boy
By Susan Sachs,
The New York Times
| 08. 15. 2001
The pitch could not be more direct. The intended audience could not
be more specific.
"Desire a Son?" asked an advertisement in recent editions
of India Abroad, a weekly newspaper for Indian expatriates in the
United States and Canada.
"Choosing the sex of your baby: new scientific reality,"
declared another in the same publication. A third ad ran in both India
Abroad and the North American edition of The Indian Express. "Pregnant?"
it said. "Wanna know the gender of your baby right now?"
Some people would call it niche marketing — an effort by companies
to promote their products to one of the country's fastest-growing
ethnic groups.
But the products in question are not chewing gum or financial services.
They are procedures to preselect the sex of a child or, in the case
of one advertiser, to identify the sex of the fetus as early as five
weeks into a pregnancy. And the target market is immigrants from India,
where sex-determination tests were outlawed seven years ago in a still
unsuccessful effort to thwart the widespread practice of aborting
female...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...